Beximco Pharmaceuticals (DHA:BXPHARMA) Market Cap : BDT47,645 Mil (As of Jun. 08, 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Beximco Pharmaceuticals's share price for the quarter that ended in Mar. 2024 was BDT116.4. Beximco Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 446 Mil. Therefore, Beximco Pharmaceuticals's market cap for the quarter that ended in Mar. 2024 was BDT51,927 Mil.

Beximco Pharmaceuticals's quarterly market cap stayed the same from Jun. 2023 (BDT65,222 Mil) to Dec. 2023 (BDT65,222 Mil) but then declined from Dec. 2023 (BDT65,222 Mil) to Mar. 2024 (BDT51,927 Mil).

Beximco Pharmaceuticals's annual market cap declined from Jun. 2021 (BDT79,096 Mil) to Jun. 2022 (BDT68,969 Mil) and declined from Jun. 2022 (BDT68,969 Mil) to Jun. 2023 (BDT65,222 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beximco Pharmaceuticals's Enterprise Value for Today is BDT53,712 Mil.

Beximco Pharmaceuticals Market Cap Historical Data

The historical data trend for Beximco Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Market Cap Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Market Cap

Get a 7-Day Free Trial

33,863.96

28,064.50

79,095.66

68,968.92

65,221.57

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															65,221.57	65,221.57	65,221.57	65,221.57	51,927.44

Competitive Comparison of Beximco Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beximco Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Market Cap falls into.

Beximco Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Beximco Pharmaceuticals's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )	=	Share Price (A: Jun. 2023 )	*	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	BDT146.2	*	446.112
	=	BDT65,222

Beximco Pharmaceuticals's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	BDT116.4	*	446.112
	=	BDT51,927

Beximco Pharmaceuticals (DHA:BXPHARMA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Beximco Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Market Cap

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines